<?xml version="1.0" encoding="UTF-8"?>
<ref id="B45-vaccines-08-00307">
 <label>45.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Wu</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Li</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Du</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Zou</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Hong</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Yuan</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ren</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Tai</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Kong</surname>
    <given-names>Y.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Neutralization of Zika virus by germline-like human monoclonal antibodies targeting cryptic epitopes on envelope domain III</article-title>
  <source>Emerg. Microbes Infect.</source>
  <year>2017</year>
  <volume>6</volume>
  <fpage>e89</fpage>
  <pub-id pub-id-type="doi">10.1038/emi.2017.79</pub-id>
  <?supplied-pmid 29018252?>
  <pub-id pub-id-type="pmid">29018252</pub-id>
 </element-citation>
</ref>
